Reckitt Benckiser Aktie
56,86
EUR
±0,00
EUR
±0,00
%
47,50
GBP
-0,33
GBP
-0,69
%
Reckitt Benckiser Aktie Analyse
01.11.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
18.09.24 | Reckitt Benckiser Buy | UBS AG | |
21.08.24 | Reckitt Benckiser Outperform | Bernstein Research | |
29.07.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
29.07.24 | Reckitt Benckiser Overweight | Barclays Capital | |
25.07.24 | Reckitt Benckiser Outperform | Bernstein Research | |
24.07.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
24.07.24 | Reckitt Benckiser Buy | UBS AG | |
Werbung
|
|||
24.07.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
24.07.24 | Reckitt Benckiser Outperform | Bernstein Research | |
15.07.24 | Reckitt Benckiser Outperform | Bernstein Research | |
04.07.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
03.07.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
01.07.24 | Reckitt Benckiser Buy | UBS AG | |
14.06.24 | Reckitt Benckiser Outperform | Bernstein Research | |
30.05.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
23.05.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
21.05.24 | Reckitt Benckiser Buy | UBS AG | |
21.05.24 | Reckitt Benckiser Outperform | Bernstein Research | |
13.05.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
10.05.24 | Reckitt Benckiser Buy | UBS AG | |
07.05.24 | Reckitt Benckiser Buy | UBS AG | |
25.04.24 | Reckitt Benckiser Overweight | Barclays Capital | |
24.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
24.04.24 | Reckitt Benckiser Overweight | Barclays Capital | |
24.04.24 | Reckitt Benckiser Outperform | Bernstein Research | |
24.04.24 | Reckitt Benckiser Buy | UBS AG | |
24.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
22.04.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
18.04.24 | Reckitt Benckiser Overweight | Barclays Capital | |
05.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
02.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
28.03.24 | Reckitt Benckiser Overweight | Barclays Capital | |
28.03.24 | Reckitt Benckiser Buy | UBS AG | |
19.03.24 | Reckitt Benckiser Buy | UBS AG | |
18.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
18.03.24 | Reckitt Benckiser Buy | UBS AG | |
18.03.24 | Reckitt Benckiser Overweight | Barclays Capital | |
18.03.24 | Reckitt Benckiser Outperform | Bernstein Research | |
15.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
08.03.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
06.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
04.03.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
01.03.24 | Reckitt Benckiser Kaufen | DZ BANK | |
29.02.24 | Reckitt Benckiser Overweight | Barclays Capital | |
28.02.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
28.02.24 | Reckitt Benckiser Buy | UBS AG | |
28.02.24 | Reckitt Benckiser Outperform | Bernstein Research | |
28.02.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
28.02.24 | Reckitt Benckiser Outperform | RBC Capital Markets |